view points: could pfizer\'s tofacitinib beat expectation and gain approval next month as a...

2

Click here to load reader

Upload: rhonda-greenapple

Post on 07-Jul-2015

158 views

Category:

Documents

0 download

Report

Download

Embed Size (px):

TRANSCRIPT

$Page 1: View Points: Could Pfizer\'s tofacitinib beat expectation and gain approval next month as a second-line therapy?$

$Page 2: View Points: Could Pfizer\'s tofacitinib beat expectation and gain approval next month as a second-line therapy?$

PRODUCT MONOGRAPH - Pfizer Canada | (tofacitinib tablets for oral administration) Page 1 of 53 PRODUCT MONOGRAPH PrXELJANZTM Tofacitinib tablets 5 mg tofacitinib (as tofacitinib citrate)

EXTENDED REPORT The JAK inhibitor tofacitinib suppresses

Pfizer Laboratories Div Pfizer Inc TRAZIMERA- trastuzumab

Annual Review 2013 - Pfizer Annual Review 2013 1 ... (methylphenidate HCl) Eliquis (apixaban) Xalkori (crizotinib) Xeljanz (tofacitinib) Inlyta (axitinib)

Maintenance of Remission With Tofacitinib Therapy in

Pfizer Sustainability

XELJANZ (TOFACITINIB) (RHEUMATOID ARTHRITIS) - FORECAST ... · forecast and market analysis to 2023 Xeljanz (tofacitinib) (Rheumatoid Arthritis) – Forecast and Market Analysis to

EXTENDED REPORT The JAK inhibitor tofacitinib ...EXTENDED REPORT The JAK inhibitor tofacitinib suppresses synovial JAK1-STAT signalling in rheumatoid arthritis D L Boyle,1 K Soma,2

Placebo-Controlled Trial of Tofacitinib Monotherapy in RA Agust 2012

Original research Long-term safety of tofacitinib up to 9.5 years: a … · Original research Long-term safety of tofacitinib up to 9.5 years: a comprehensive integrated analysis

Australian Public Assessment Report for Tofacitinib (as ...€¦ · Web viewAustralian Public Assessment Report for Tofacitinib (as citrate) Proprietary Product Name: Xeljanz. Sponsor:

Atlas PFizer de Parasitologia Clinica Veterinaria-pFizer

Tofacitinib for moderately to severely active ulcerative

AUSTRALIAN PRODUCT INFORMATION XELJANZÒ · Attachment 1: Product information AusPAR - Xeljanz - Tofacitinib - Pfizer Australia Pty Ltd - PM-2017-04764-1-1 – FINAL 10 September

The experience with tofacitinib in Humanitas IBD center, from … · 2019-06-01 · Study design: OCTAVE Induction studies Primary Objectives 1. Compare the efficacy of tofacitinib

Pfizer CentreOne

Expectation & Variance 1 Expectation

EXTENDED REPORT Comparing the effects of tofacitinib ... · ability4 and impact on general health and quality of life.5 Tofacitinib is an oral Janus kinase (JAK) inhibitor for the

Safety and maintenance of response for tofacitinib ...rmdopen.bmj.com/content/rmdopen/3/2/e000491.full.pdfadverse events with tofacitinib 5 mg and 10 mg twice daily, respectively,

Pfizer Statement on Update to XELJANZ (tofacitinib ......Pfizer Statement on Update to XELJANZ® (tofacitinib) Prescribing Information in the United States NEW YORK, N.Y., July 26,

CP.PHAR.267 Tofacitinib (Xeljanz, Xeljanz XR)...Revision Log See . Important Reminder at the end of this policy for important regulatory and legal information. Description Tofacitinib

Webinar: SFI-Pfizer Biotherapeutics Innovation Award ...chiefscientificadviser.ie/...pfizer-biotherapeutic/... · Objectives Create new collaborations between Pfizer and academics

Xeljanz-Tofacitinib FDA Label_DrAlanBauman

Ruxolitinib and Tofacitinib Are Potent and Selective ... · Ruxolitinib and Tofacitinib Are Potent and Selective Inhibitors of ... removed to achieve a functional cure or systemic

Attachment: Product Information: Tofacitinib (as … · Web viewAttachment 1: Product AusPAR- Xeljanz - tofacitinib - Pfizer Australia Pty Ltd - PM-2017-03802-1-3 FINAL 25 September

Pfizer Announces , on behalf of the BMS-Pfizer Alliance, a

Pfizer Registration contractors-ENGLISH-V4file.onyxonlinelearning.com/PFIZER - PORTAL/Pfizer...3 HANDBOOK Pfizer employee ONYX Registration Tool Version 4 Pfizer employees are authorized

Tofacitinib in patients with ankylosing spondylitis: a

Tofacitinib, an Oral Janus Kinase Inhibitor: Pooled Efficacy and Safety … · 2018-11-23 · ORIGINAL RESEARCH Tofacitinib, an Oral Janus Kinase Inhibitor: Pooled Efﬁcacy and Safety

Tofacitinib for moderate to severe rheumatoid arthritis

EXTENDED REPORT Long-term safety of tofacitinib for the …ard.bmj.com/content/annrheumdis/76/7/1253.full.pdf · EXTENDED REPORT Long-term safety of tofacitinib for the treatment

58766 Pfizer Prospectus · PROSPECTUS Pfizer Inc. Shareholder Investment Program ... Plan of Distribution ... consumer products. Every day, Pfizer colleagues

alprazolam: List of nationally authorised medicinal ......Alprazolam "Pfizer", tabletter not available 14630 PFIZER APS DK Alprazolam "Pfizer", tabletter not available 14213 PFIZER

Case Report Tofacitinib Citrate for Ulcerative Keratitis ...downloads.hindawi.com/journals/crirh/2014/403452.pdf · Case Report Tofacitinib Citrate for Ulcerative Keratitis in a Patient